Sera Prognostics Stock Performance
| SERA Stock | USD 2.65 0.05 1.92% |
The entity has a beta of 1.95, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sera Prognostics will likely underperform. At this point, Sera Prognostics has a negative expected return of -0.13%. Please make sure to validate Sera Prognostics' expected short fall, and the relationship between the value at risk and daily balance of power , to decide if Sera Prognostics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Sera Prognostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Actual Historical Performance (%)
One Day Return 0.39 | Five Day Return 10.64 | Year To Date Return (13.33) | Ten Year Return (78.15) | All Time Return (78.15) |
1 | Heres Why Were Watching Sera Prognostics Cash Burn Situation | 11/17/2025 |
2 | Disposition of 32203 shares by Paul Kearney of Sera Prognostics at 1.62 subject to Rule 16b-3 | 12/02/2025 |
3 | Disposition of 292 shares by Mirza Mansoor Raza of Sera Prognostics at 3.05 subject to Rule 16b-3 | 12/05/2025 |
4 | Disposition of 1560 shares by Lawrence Sandra Aj of Sera Prognostics at 3.05 subject to Rule 16b-3 | 12/08/2025 |
5 | Financial Analysis CarePayment Technologies versus Sera Prognostics | 12/09/2025 |
6 | Disposition of 873 shares by Austin Aerts of Sera Prognostics at 3.31 subject to Rule 16b-3 | 12/10/2025 |
7 | Sera Prognostics CFO Sells 15,905.28 in Stock | 12/11/2025 |
8 | Sera Prognostics Stock Rating Upgraded by Jefferies Financial Group | 12/17/2025 |
9 | Sera Prognostics chief scientific officer sells shares for 27,090 - MSN | 12/29/2025 |
10 | Sera Prognostics Unveils Strategy to Redefine Pregnancy Care - TipRanks | 01/08/2026 |
11 | Acquisition by Barlow Jane F of 25000 shares of Sera Prognostics at 1.6 subject to Rule 16b-3 | 01/26/2026 |
12 | Disposition of 2000 shares by Robert Harrison of Sera Prognostics at 2.97 subject to Rule 16b-3 | 01/27/2026 |
13 | Sera Prognostics Shares Down 2.8 percent - Heres Why - MarketBeat | 01/30/2026 |
14 | Disposition of 30920 shares by Kamdar Kim P. of Sera Prognostics subject to Rule 16b-3 | 02/04/2026 |
15 | Latest Global Cell Therapy Raw Materials Market SizeShare Worth USD 29.3 Billion by 2035 at a 18.9 percent CAGR Custom Market Insights | 02/11/2026 |
| Begin Period Cash Flow | 3.9 M | |
| Total Cashflows From Investing Activities | 11.7 M |
Sera Prognostics Relative Risk vs. Return Landscape
If you would invest 306.00 in Sera Prognostics on November 15, 2025 and sell it today you would lose (41.00) from holding Sera Prognostics or give up 13.4% of portfolio value over 90 days. Sera Prognostics is currently does not generate positive expected returns and assumes 4.5951% risk (volatility on return distribution) over the 90 days horizon. In different words, 41% of stocks are less volatile than Sera, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Sera Prognostics Target Price Odds to finish over Current Price
The tendency of Sera Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.65 | 90 days | 2.65 | about 92.34 |
Based on a normal probability distribution, the odds of Sera Prognostics to move above the current price in 90 days from now is about 92.34 (This Sera Prognostics probability density function shows the probability of Sera Stock to fall within a particular range of prices over 90 days) .
Sera Prognostics Price Density |
| Price |
Predictive Modules for Sera Prognostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sera Prognostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sera Prognostics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sera Prognostics is not an exception. The market had few large corrections towards the Sera Prognostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sera Prognostics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sera Prognostics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 1.95 | |
σ | Overall volatility | 0.35 | |
Ir | Information ratio | 0.02 |
Sera Prognostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sera Prognostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sera Prognostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sera Prognostics generated a negative expected return over the last 90 days | |
| Sera Prognostics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 77 K. Net Loss for the year was (32.9 M) with loss before overhead, payroll, taxes, and interest of (59 K). | |
| Sera Prognostics currently holds about 106.91 M in cash with (14.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 58.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: Latest Global Cell Therapy Raw Materials Market SizeShare Worth USD 29.3 Billion by 2035 at a 18.9 percent CAGR Custom Market Insights |
Sera Prognostics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sera Stock often depends not only on the future outlook of the current and potential Sera Prognostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sera Prognostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.2 M | |
| Cash And Short Term Investments | 46.2 M |
Sera Prognostics Fundamentals Growth
Sera Stock prices reflect investors' perceptions of the future prospects and financial health of Sera Prognostics, and Sera Prognostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sera Stock performance.
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.25 | ||||
| Operating Margin | (561.25) % | ||||
| Current Valuation | 59.1 M | ||||
| Shares Outstanding | 37.63 M | ||||
| Price To Book | 1.22 X | ||||
| Price To Sales | 1,052 X | ||||
| Revenue | 77 K | ||||
| Gross Profit | (59 K) | ||||
| EBITDA | (32.04 M) | ||||
| Net Income | (32.9 M) | ||||
| Cash And Equivalents | 106.91 M | ||||
| Cash Per Share | 3.45 X | ||||
| Total Debt | 840 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.80 X | ||||
| Book Value Per Share | 2.13 X | ||||
| Cash Flow From Operations | (14.19 M) | ||||
| Earnings Per Share | (0.76) X | ||||
| Market Capitalization | 99.96 M | ||||
| Total Asset | 72.58 M | ||||
| Retained Earnings | (279.79 M) | ||||
| Working Capital | 22.83 M | ||||
About Sera Prognostics Performance
By analyzing Sera Prognostics' fundamental ratios, stakeholders can gain valuable insights into Sera Prognostics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sera Prognostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sera Prognostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.41) | (0.43) | |
| Return On Capital Employed | (0.69) | (0.72) | |
| Return On Assets | (0.41) | (0.43) | |
| Return On Equity | (0.62) | (0.65) |
Things to note about Sera Prognostics performance evaluation
Checking the ongoing alerts about Sera Prognostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sera Prognostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sera Prognostics generated a negative expected return over the last 90 days | |
| Sera Prognostics has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 77 K. Net Loss for the year was (32.9 M) with loss before overhead, payroll, taxes, and interest of (59 K). | |
| Sera Prognostics currently holds about 106.91 M in cash with (14.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 58.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: Latest Global Cell Therapy Raw Materials Market SizeShare Worth USD 29.3 Billion by 2035 at a 18.9 percent CAGR Custom Market Insights |
- Analyzing Sera Prognostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sera Prognostics' stock is overvalued or undervalued compared to its peers.
- Examining Sera Prognostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sera Prognostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sera Prognostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sera Prognostics' stock. These opinions can provide insight into Sera Prognostics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sera Stock analysis
When running Sera Prognostics' price analysis, check to measure Sera Prognostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sera Prognostics is operating at the current time. Most of Sera Prognostics' value examination focuses on studying past and present price action to predict the probability of Sera Prognostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sera Prognostics' price. Additionally, you may evaluate how the addition of Sera Prognostics to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |